At a glance
ClinicalIndex Comparison RecordN/ACompleted· 261 enrolled
Drug / intervention
PODEYE TORIC Monofocal IOL +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Investigation of the Safety and Effectiveness of Monofocal PODEYE TORIC Intraocular Lens (IOL)
In Brief
A clinical study evaluating PODEYE TORIC Monofocal IOL and Alcon AcrySof SA60AT Monofocal IOL for Eye Diseases and 4 related conditions. Completed, enrolled 261 participants.
Detailed Summary
This study is a prospective, multicenter, randomized, double masked trial comparing an investigational Monofocal Toric intraocular lens (IOL) (PODEYE TORIC CYL 1.5 D) and a commercially available non-toric monofocal IOL.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEye Diseases, Postcataract Aphakia, Cataract, Lens Opacities, Astigmatism
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20252026
First PostedMay 2024
Enrollment StartJun 2024
Primary CompletionNov 2025
TodayJul 2026
First PostedMay 3, 2024
Enrollment StartJun 28, 2024
Primary CompletionNov 6, 2025
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 2.2 years ago
Interventions
PODEYE TORIC Monofocal IOLdevice
Cataractous lens will be removed in the study eyes and the PODEYE TORIC IOL (1.5 D) will be implanted in the capsular bag.
Alcon AcrySof SA60AT Monofocal IOLdevice
Cataractous lens will be removed in the study eyes and the Alcon AcrySof SA60AT Monofocal IOL will be implanted in the capsular bag.